Back to search
FDAFDA · Food and drugs·Recall number Z-0992-2019

VITROS Chemistry Products Na+ Slides, Catalog Number 8379034 For in vitro diagnostic use only. VITROS Na+ Slides quantitatively measure sodium (Na+) concentration in serum, plasma, and urine using VITROS 250/350/950/5,1 FS and 4600 Chemistry Systems and the VITROS 5600 Integrated System.

Published March 20, 2019 · Recall initiated: January 22, 2019

Summary

FDA records medical device Class II recall Z-0992-2019, published March 20, 2019 and initiated January 22, 2019. Recalling firm: Ortho-Clinical Diagnostics; Status: Terminated; Reported quantity: 1448; Lot: Lot 4221-0998-3223. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Imprecision in the affected lot may produce negatively or positively biased patient sample and quality control fluid results.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Ortho-Clinical Diagnostics
Distributor
US Distribution to states of: AL, CA, CT, FL, HI, IA, ID, IL, LA, MI, MO, MS, NC, NM, NY, OK, PA, TX, WV, and WY; and internationally to: Canada.
Lot
Lot 4221-0998-3223
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was VITROS Chemistry Products Na+ Slides, Catalog Number 8379034 For in vitro diagnostic use only. VITROS Na+ Slides quantitatively measure sodium (Na+) concentration in serum, plasma, and urine using VITROS 250/350/950/5,1 FS and 4600 Chemistry Systems and the VITROS 5600 Integrated System. recalled?

Yes. FDA published recall Z-0992-2019 on March 20, 2019. Reported hazard: Imprecision in the affected lot may produce negatively or positively biased patient sample and quality control fluid results.

What should I do if I have this product?

Voluntary: Firm initiated · Letter